Table 2.

Dissolution data and descriptive statistics of nine meloxicam tablet brands.

Time (min)	Brand	mean%	RSD	Lower limit	Upper limit
	I	32.3	30.4	14.0	48.4
	II	24.2	8.6	20.8	27.8
	III	60.3	9.8	49.4	67.7
	IV	59.9	9.8	51.7	66.8
5	V	28.7	8.3	25.2	32.0
	VI	69.8	13.4	49.7	82.7
	VII	66.7	10.1	56.5	78.3
	VIII	78.8	1.9	76.0	81.2
	IX	59.2	2.6	56.7	62.8
	I	66.9	7.5	58.6	74.0
	II	64.2	8.6	55.0	74.2
	III	88.7	6.5	77.0	96.6
	IV	83.0	5.4	77.2	89.2
15	V	74.0	2.5	71.4	77.2
	VI	86.9	7.0	79.3	94.8
	VII	89.8	8.7	84.9	113.3
	VIII	97.8	2.5	95.3	102.5
	IX	85.0	4.6	78.1	92.9
	I	83.2	5.7	74.4	88.7
	II	79.5	8.3	68.8	89.0
	III	98.5	7.0	83.9	109.7
	IV	93.4	2.8	88.9	98.2
30	V	92.2	2.9	88.6	96.7
	VI	91.9	4.3	87.0	97.8
	VII	99.7	3.6	95.8	107.4
	VIII	102.2	1.7	99.7	105.4
	IX	99.9	3.0	92.4	105.6
	I	89.6	5.7	80.8	97.0
	II	95.0	4.7	85.8	102.8
	III	100.1	6.9	88.0	112.4
	IV	97.9	2.4	93.3	102.4
45	V	93.9	1.4	91.6	96.1
	VI	93.2	5.5	85.3	102.0
	VII	98.0	3.6	94.4	105.6
	VIII	102.2	2.7	99.4	108.1
	IX	105.0	4.0	98.7	111.0
	I	97.0	3.1	90.0	102.0
	II	98.8	5.2	87.1	107.0
	III	101.5	6.2	89.7	114.1
	IV	98.5	4.3	89.6	107.1
60	V	95.3	2.0	92.9	98.8
	VI	96.0	5.9	89.2	109.5
	VII	98.4	5.8	91.4	106.4
	VIII	103.0	0.7	101.8	104.4
	IX	105.8	2.6	100.0	110.4